Skip to main content
. Author manuscript; available in PMC: 2014 Sep 15.
Published in final edited form as: Cancer Biol Ther. 2003 Nov-Dec;2(6):630–635.

Table 1.

Papers demonstrating IGF Contributions to Cancer Treatment Resistance

Cancer Treatment Reference
Breast Herceptin Lu et al. J Natl Cancer Inst 2001; 93:1852.
Doxorubicin, Taxol Beech et al. Oncol Rep 2001; 8:325.
Radiation Langeland et al. Oncol Rep 2002; 9:397.
Taxol Mamay et al. Oncogene 2003; 22:602.
Colorectal 5FU, Radiation Perer et al. J Surg Res 2000; 94:1.
Lung (small cell) Etoposide Krystal et al. Molec Cancer Ther 2002; 1:913.
Thyroid Apo2L/TRAIL Poulaki et al. Am J Pathol 2002; 161:643.
Pancreas COX-2 inhibitors Levitt and Pollak. Cancer Res 2002; 62:7372.
Rhabdomyosarcoma Rapamycin Thimmaiah et al. Cancer Res 2003; 63:364.
Sarcoma mets Doxorubicin Beech et al. Oncol Rep 2003; 10:181.
Leukemia Drugs, ATRA Neri et al. Molec Cancer Res 2003; 1:234.
Multiple myeloma Apo2L/TRAIL Mitsiades et al. Oncogene 2002; 21:5673.